Gordon Guyatt
Clinical epidemiologist and evidence-based medicine pioneer
Gordon Guyatt coined the term 'evidence-based medicine' in 1991 and spent decades teaching clinicians worldwide how to evaluate research rigorously. Yet when it came to paediatric gender medicine, he signed advocacy statements endorsing these treatments as medically necessary — without reading them carefully. His candid admission on the Beyond Gender podcast raises urgent questions for Irish healthcare and policymakers.
Gordon Guyatt is a Distinguished Professor at McMaster University in Canada and one of the most influential figures in modern medicine. In 1991 he coined the term 'evidence-based medicine', launching a movement that reshaped how clinicians and health systems around the world assess whether treatments actually work. He helped develop the GRADE system — the gold-standard framework for rating the certainty of medical evidence — now adopted by bodies including the World Health Organization and health authorities across dozens of countries.
Given that background, Guyatt's involvement in systematic reviews of paediatric gender interventions carries particular weight. Those reviews — examining the evidence base for puberty blockers and cross-sex hormones in children and adolescents — returned a troubling finding: the quality of the evidence was low. By the very standards Guyatt himself helped create, the research underpinning these treatments could not support strong clinical recommendations.
What makes his appearance on Beyond Gender all the more striking is the admission at the heart of episode 36, Gordon Guyatt's Confession: What the Father of Evidence-Based Medicine Didn't Read (September 2025). Speaking with Stella O'Malley, Mia Hughes and Dr Bret Alderman, Guyatt acknowledged that he had signed advocacy statements endorsing paediatric gender treatments as medically necessary — without reading those statements carefully. For the man who built the intellectual architecture for scrutinising medical claims, the candour was remarkable.
For Irish listeners, the conversation lands at a pivotal moment. Ireland is still shaping its approach to gender-related healthcare for young people, and the institutions responsible — the HSE, clinical networks, and the CAMHS services that feed into them — rely on exactly the kind of evidence hierarchies Guyatt pioneered. When the father of evidence-based medicine questions whether that standard was applied to paediatric gender medicine, it is a question Irish policymakers and clinicians cannot afford to ignore.
